⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002090209

Caudill Cortney

Reports to the SEC for 1 company · SAN DIEGO, CA

Transactions

19

Companies

1

Filings

5

CIK

0002090209

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-10	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF OPERATING OFFICER	MExercise/Conversion	+1,546 sh	$33.51	+$51.8K	15,912
2026-03-10	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF OPERATING OFFICER	SSale	−8,857 sh	$67.64	−$599K	7,055
2026-03-10	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	SVP, CHIEF OPERATING OFFICER	MExercise/Conversion	−1,546 sh	$33.51	−$51.8K	67,678
2026-03-09	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF OPERATING OFFICER	MExercise/Conversion	+20K sh	$33.51	+$670K	34,366
2026-03-09	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF OPERATING OFFICER	SSale	−17.9K sh	$67.75	−$1.21M	16,466
2026-03-09	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF OPERATING OFFICER	SSale	−2,100 sh	$68.25	−$143K	14,366
2026-03-09	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockM Exercise/Conversion	SVP, CHIEF OPERATING OFFICER	MExercise/Conversion	−20K sh	$33.51	−$670K	69,224
2026-02-20	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF OPERATING OFFICER	MExercise/Conversion	+2,666 sh	—	—	15,403
2026-02-20	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, CHIEF OPERATING OFFICER	FTax Payment	−1,037 sh	$70.98	−$73.6K	14,366
2026-02-20	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, CHIEF OPERATING OFFICER	MExercise/Conversion	−2,666 sh	—	—	7,998
2026-02-09	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	SVP, CHIEF OPERATING OFFICER	AAward	+14K sh	—	—	14,047
2026-02-09	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsA Award	SVP, CHIEF OPERATING OFFICER	AAward	+13K sh	—	—	13,047
2026-02-09	HALOHALOZYME THERAPEUTICS, INC. · Performance Stock UnitsA Award	SVP, CHIEF OPERATING OFFICER	AAward	+2,403 sh	—	—	13,886
2026-02-09	HALOHALOZYME THERAPEUTICS, INC. · Performance Stock UnitsA Award	SVP, CHIEF OPERATING OFFICER	AAward	+14.8K sh	—	—	14,751
2025-11-01	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, CHIEF OPERATING OFFICER	MExercise/Conversion	+9,326 sh	—	—	17,000
2025-11-01	HALOHALOZYME THERAPEUTICS, INC.S Sale	SVP, CHIEF OPERATING OFFICER	SSale	−4,263 sh	$65.19	−$278K	12,737
2025-11-01	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, CHIEF OPERATING OFFICER	MExercise/Conversion	−9,326 sh	—	—	18,651
2025-10-03	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	SVP, CHIEF OPERATING OFFICER	AAward	+9,031 sh	—	—	9,031
2025-10-03	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsA Award	SVP, CHIEF OPERATING OFFICER	AAward	+3,625 sh	—	—	3,625

Recent filings

5

Accepted (ET)
Mar 104
Caudill Cortney0001159036-26-000033
SEC(opens sec.gov)
Feb 244
Caudill Cortney0001159036-26-000031
SEC(opens sec.gov)
Feb 114
Caudill Cortney0001159036-26-000017
SEC(opens sec.gov)
Dec 194
Caudill Cortney0001159036-25-000075
SEC(opens sec.gov)
Oct 64
Caudill Cortney0002090209-25-000005
SEC(opens sec.gov)

Companies

1

HALOZYME THERAPEUTICS, INC.SVP, CHIEF OPERATING OFFICERHALO

Address

C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL

SAN DIEGO, CA, 92130